Literature DB >> 17729365

Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis.

Christian Kremser1, Thomas Trieb, Ansgar Rudisch, Werner Judmaier, Alexander de Vries.   

Abstract

PURPOSE: To describe details about the implementation of a dynamic T(1)-mapping technique and a simple data analysis strategy that can be used to predict therapy outcome in primary rectal carcinoma and to investigate the physiologic meaning of the obtained parameter.
MATERIALS AND METHODS: Contrast-enhanced dynamic T(1) mapping was achieved with a snapshot fast low-angle shot (FLASH) T(1) mapping sequence implemented on a 1.5 T MR scanner. This method was applied to 58 patients with primary rectal cancer before onset of chemoradiation therapy. A simple data analysis strategy based on the calculation of the maximum slope of the tissue concentration-time curve divided by the maximum of the arterial input function (AIF) was used as a measure of tumor microcirculation (PI values).
RESULTS: The snapshot FLASH (SFL) T(1)-mapping technique is accurate and sensitive enough to detect inhomogeneous uptake kinetics within tumor tissue. Classifying the patients into two groups according to therapy response showed lower mean PI values for responders as compared to nonresponders. PI was found to combine information about permeability surface area product (PS) and blood volume.
CONCLUSIONS: The described method based on dynamic T(1) mapping has the potential to be a clinical tool for predicting therapy outcome of preoperative chemoradiation in patients with primary rectal carcinoma. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729365     DOI: 10.1002/jmri.21034

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  20 in total

1.  Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?

Authors:  Lian-Ming Wu; Jiong Zhu; Jiani Hu; Yan Yin; Hai-Yan Gu; Jia Hua; Jie Chen; Jian-Rong Xu
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

2.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

3.  Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line.

Authors:  Hamed Manoochehri Khoshinani; Saeid Afshar; Abdolazim Sedighi Pashaki; Ali Mahdavinezhad; Safora Nikzad; Rezvan Najafi; Razieh Amini; Mohammad Hadi Gholami; Alireza Khoshghadam; Massoud Saidijam
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

4.  Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.

Authors:  Koji Yasuda; Eiji Sunami; Kazushige Kawai; Hirokazu Nagawa; Joji Kitayama
Journal:  J Gastrointest Cancer       Date:  2012-06

5.  Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.

Authors:  Joji Kitayama; Koji Yasuda; Kazushige Kawai; Eiji Sunami; Hirokazu Nagawa
Journal:  Radiat Oncol       Date:  2010-06-03       Impact factor: 3.481

Review 6.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 7.  How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?

Authors:  Paola De Nardi; Michele Carvello
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

Review 8.  MRI in local staging of rectal cancer: an update.

Authors:  Umit Tapan; Mustafa Ozbayrak; Servet Tatlı
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

9.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

10.  The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer.

Authors:  Daichi Ishikawa; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Takuya Tokunaga; Jun Higashijima; Kozo Yoshikawa; Mitsuo Shimada
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.